The Summit encompasses industry case studies and research presentations reflecting the current state of predictive toxicology testing and innovative tools being developed. Predictive testing will be covered with an emphasis on pre-clinical studies in several therapeutic areas including liver toxicity, oncology and cardio toxicity.
This meeting is designed to provoke you to address your biggest challenges in the predictive ability of new research subjects with a focus on:
– The transition of the Toxicology industry from animal models to human tissue models
– The evolution of 3D Models
– The use of Stem Cells in Predictive Testing
– Innovative uses of Biomarkers
Moreover, provide you with an opportunity to hear the best case-studies from such major industry players as GSK, Merck, Novartis, Janssen and more.